BATE KENNETH 4

Accession 0001628280-25-050668

CIK 0001157601other

View on SEC.gov Company Profile

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 4:20 PM ET

Size

31.5 KB

Accession

0001628280-25-050668

Insider Transaction Report

Form 4

Period: 2025-11-05

MADRIGAL PHARMACEUTICALS, INC.MDGL

BATE KENNETH

Director

Transactions

Sale
Common Stock
2025-11-05$482.41/sh−1,284$619,417→ 12,896 total
Sale
Common Stock
2025-11-05$484.78/sh−1,931$936,105→ 8,896 total
Sale
Common Stock
2025-11-05$489.09/sh−696$340,409→ 3,590 total
Sale
Common Stock
2025-11-05$490.98/sh−30$14,729→ 2,627 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-05−5,470→ 0 total
Exercise: $9.45Exp: 2026-07-22→ Common Stock (5,470 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-05−10,000→ 0 total
Exercise: $303.79Exp: 2028-06-19→ Common Stock (10,000 underlying)
Exercise/Conversion
Common Stock
2025-11-05$9.45/sh+5,470$51,691→ 8,097 total
Exercise/Conversion
Common Stock
2025-11-05$280.04/sh+1,105$309,444→ 19,202 total
Sale
Common Stock
2025-11-05$481.13/sh−3,259$1,567,995→ 14,180 total
Sale
Common Stock
2025-11-05$483.41/sh−2,069$1,000,170→ 10,827 total
Sale
Common Stock
2025-11-05$485.54/sh−1,008$489,421→ 7,888 total
Sale
Common Stock
2025-11-05$486.73/sh−827$402,530→ 7,061 total
Exercise/Conversion
Stock Option (Right to Buy)
2025-11-05−1,105→ 0 total
Exercise: $280.04Exp: 2031-06-25→ Common Stock (1,105 underlying)
Exercise/Conversion
Common Stock
2025-11-05$303.79/sh+10,000$3,037,900→ 18,097 total
Sale
Common Stock
2025-11-05$480.24/sh−1,763$846,663→ 17,439 total
Sale
Common Stock
2025-11-05$487.49/sh−2,775$1,352,796→ 4,286 total
Sale
Common Stock
2025-11-05$489.95/sh−933$457,119→ 2,657 total

Footnotes (12)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $479.66 to $480.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
[F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $489.74 to $490.7125, inclusive.
[F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $490.7625 to $491.42, inclusive.
[F12]The shares underlying this option are fully vested and exercisable.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $480.71 to $481.68, inclusive.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $481.84 to $482.71, inclusive.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $483.00 to $483.92, inclusive.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $484.02 to $485.015, inclusive.
[F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $485.10 to $486.04, inclusive.
[F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $486.10 to $486.99, inclusive.
[F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $487.13 to $488.09, inclusive.
[F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $488.74 to $489.49, inclusive.

Documents

1 file

4
wk-form4_1762550418.xmlPrimary
FORM 4

Issuer

MADRIGAL PHARMACEUTICALS, INC.

CIK 0001157601

→

Entity typeother

Related Parties

filerCIK 0001210238

Filing Metadata

Form type: 4
Filed: Nov 6, 7:00 PM ET
Accepted: Nov 7, 4:20 PM ET
Size: 31.5 KB

View on SEC.gov